RECRUITING

Association of Plant-based Diet and Gut Microbiome Signature with Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma.

Official Title

Exploring the Relationship Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma Patients

Quick Facts

Study Start:2024-08-05
Study Completion:2027-08-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06595160

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * \* Age ≥ 18 years with signed informed consent form
  2. * Patients must have a histological diagnosis of PDAC
  3. * Resectable or borderline resectable PDAC on imaging
  1. * \* Patients with locally advanced and metastatic stage IV PDAC
  2. * Patients who have already received or completed neoadjuvant chemotherapy for PDAC
  3. * Patients with active malignancy receiving systemic therapy

Contacts and Locations

Study Contact

Mihir M. Shah, MD, FACS, FSSO
CONTACT
404-778-3307
mihir.m.shah@emory.edu

Principal Investigator

Mihir M Shah
PRINCIPAL_INVESTIGATOR
Emory University Hospital/Winship Cancer Institute

Study Locations (Sites)

Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322
United States

Collaborators and Investigators

Sponsor: Emory University

  • Mihir M Shah, PRINCIPAL_INVESTIGATOR, Emory University Hospital/Winship Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-05
Study Completion Date2027-08-07

Study Record Updates

Study Start Date2024-08-05
Study Completion Date2027-08-07

Terms related to this study

Additional Relevant MeSH Terms

  • Borderline Resectable Pancreatic Ductal Adenocarcinoma
  • Resectable Pancreatic Ductal Adenocarcinoma
  • Stage I Pancreatic Cancer AJCC V8